Long-term patency and complications of single orifice hepatic venous outflow reconstruction in right lobe graft living donor liver transplantation: A Vietnamese center experience

右叶活体肝移植中单孔肝静脉流出道重建的长期通畅率和并发症:越南一家中心的经验

阅读:1

Abstract

BACKGROUNDS/AIMS: Reconstruction of hepatic venous outflow is crucial in living donor liver transplantation (LDLT) to prevent graft congestion. This study evaluated the feasibility, long-term patency, complications, and survival rates of single-orifice hepatic venous outflow reconstruction using right lobe grafts. METHODS: A prospective study was conducted involving 52 patients who underwent LDLT with right lobe grafts at 108 Military Central Hospital, Vietnam, from January 2019 to December 2020, with follow-up extending until December 2024. The technique included forming a single triangular orifice by joining the middle hepatic vein (MHV) and right hepatic vein, utilizing extended right lobe grafts with the MHV or modified right lobe grafts where MHV reconstruction was performed using polytetrafluoroethylene grafts. Outcome measures included ultrasound, CT scans, and regular clinical follow-up. RESULTS: Ten patients (19.3%) required MHV reconstruction. Mean reconstruction time was 17.4 minutes; cold ischemic time averaged 40.9 ± 6.3 minutes. Intraoperative patency was achieved in all cases, with 96.2% showing complete graft perfusion. Five-year patency was 94.2%. MHV complications occurred in three patients (5.8%): two stenoses (3.8%, conservatively managed) and one fatal occlusion (1.9%). Anastomotic diameter ≤ 30 mm significantly increased complication risk (odds ratio [OR], 14.286; 95% confidence interval [CI]: 1.121-183.823; p = 0.011). Five-year survival was 84.6% (95% CI: 75.2%-93.9%), with rates of 100% for cirrhosis, 85.7% for hepatocellular carcinoma, and 58.8% for acute-on-chronic liver failure. CONCLUSIONS: Single-orifice hepatic venous outflow reconstruction is simple, efficient, and reliable in LDLT, achieving high long-term patency and low complication rates without cadaveric grafts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。